Donate
|
Join/Renew
|
Store
|
Member Directory
|
My SNMMI
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News and Media
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Download a Member Application
Grants, Awards, and Scholarships
Access the Phantom Analysis Toolkit
Membership Directory
Chapters
Centers of Excellence
Councils
Member Spotlight
Women in Nuclear Medicine
SNMMI Fellow
SNMMI-TS Fellow
Council and Center Internships
EDUCATION
Learning Center
Webinars
MEETINGS & EVENTS
Calendar of Events
Webinars
2024 Annual Meeting
2024 Therapeutics Conference
2024 Mid-Winter Meeting
Nuclear Medicine & Molecular Imaging Week
ADVOCACY
Coding & Reimbursement
Legislative Efforts
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
Position Statements
FDA PET Drug Manufacturing Q&A
EVIDENCE & QUALITY
Clinical Guidelines and AUC
Quality
Quality and Patient Safety
Dose Optimization
About Quality & Practice
Dosimetry
RESEARCH
Clinical Trials Network
Radiopharmaceutical Therapy Central
Radiopharmaceutical Therapy Centers of Excellence
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research: Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance - SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Career Center
About Nuclear Medicine & Molecular Imaging
International Collaboration
Outreach
Support SNMMI
Contact Us
HOME
>
SEARCH
>
SEARCH RESULTS
Refine by Audience:
Physicians
(149)
Technologists
(149)
Scientists
(149)
Media
(149)
Healthcare Provider
(148)
International
(127)
Your search for
pilot research
returned 182 results.
Selected filters:
Patients
Displaying 91 to 100 of 182 records
Sort by:
Relevancy
Date Added
Page:
<< Prev
7
…
8
…
9
…
10
…
11
…
12
…
13
…
Next >>
PSMA PET/MRI Accurately Predicts Risk of Prostate Cancer Recurrence
– Jan 5, 2023
In men recently diagnosed with intermediate or high-grade prostate cancer, PSMA PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy.
Nuclear Medicine Bone Scan Study Identifies Prevalence and Outcomes of Cardiac Amyloidosis
– Jan 3, 2023
Approximately 3% of bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality, according to new research published in JNM. This incidental finding may offer a window of opportunity for treatment.
Congress passes 2023 Consolidated Appropriations Act
– Dec 29, 2022
On December 23, 2022, the U.S. House of Representatives passed H.R. 2617, the 2023 Consolidated Appropriations Act (also referred to as the Omnibus package) by a vote of 225-201-1.
Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for Targeted Therapies
– Nov 17, 2022
A new molecular imaging radiotracer, Ga-68 PentixaFor, can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies.
PET/MRI Machine Learning Model Can Eliminate Sentinel Lymph Node Biopsy in Majority of Breast Cancer Patients
– Nov 10, 2022
Nearly 70 percent of breast cancer patients could find out if their cancer has spread to their lymph nodes without having to undergo an invasive sentinel node biopsy, according to new research published in JNM.
CTN: Enabling Accurate Quantitative PET/CT and SPECT/CT Imaging
– Oct 25, 2022
Quantitative measurements have long been a strength of nuclear medicine. There is renewed urgency for accurate, reproducible, and standardized measurements in routine clinical practice as the role of diagnostic and therapeutic radiopharmaceuticals in clinical trials and routine clinical care grows. The CTN continues to be involved in this space, with several active projects to address this need.
Novel PET Imaging Agent Detects Earliest Signs of Alzheimers Disease
– Oct 19, 2022
A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B (MAO-B) in cognitively unimpaired individuals with high beta amyloid, according to research published in the October issue of JNM.
Ultra-Low Dose Total Body PET/CT Effective for Evaluating Arthritis
– Oct 12, 2022
Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of JNM.
HomePageContent
– Oct 4, 2022
SNMMI and the Lobular Breast Cancer Alliance Announce $100,000 Research Grant
– Oct 3, 2022
SNMMI announces a new $100,000 grant to fund research on nuclear medicine imaging and treatments for lobular beast cancer. The grant is sponsored by the SNMMI Mars Shot Fund and the Lobular Breast Cancer Alliance.
Displaying 91 to 100 of 182 records
Page:
<< Prev
7
…
8
…
9
…
10
…
11
…
12
…
13
…
Next >>
Didn't find what you were looking for? Conduct a new search.